Literature DB >> 7824066

Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine.

M H Baf1, M N Subhash, K M Lakshmana, B S Rao.   

Abstract

Carbamazepine (25 mg/kg body weight) was administered intraperitoneally to adult male Wistar rats for 45 days and norepinephrine (NE), dopamine (DA) and serotonin (5-HT) levels were simultaneously assayed in discrete brain regions by high performance liquid chromatographic (HPLC) method. Experimental rats displayed no behavioral abnormalities. Body and brain weights were not significantly different from control group of rats. After exposure it was observed that norepinephrine levels were elevated in motor cortex (P < 0.01) and cerebellum (P < 0.05), while dopamine levels were decreased in these two regions (P < 0.001, P < 0.05). However, dopamine levels were increased in hippocampus (P < 0.01). Serotonin levels were significantly decreased in motor cortex (P < 0.001) and hypothalamus (P < 0.001) but increased in striatum-accumbens (P < 0.001) and brainstem (P < 0.001). These results suggest that carbamazepine may mediate its anticonvulsant effect by differential alterations of monoamine levels in discrete brain regions particularly in motor cortex and cerebellum.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7824066     DOI: 10.1007/bf00965147

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  28 in total

1.  Seizures occurring during intensive chlorpromazine therapy.

Authors:  W SCHLICHTHER; M E BRISTOW; S SCHULTZ; A L HENDERSON
Journal:  Can Med Assoc J       Date:  1956-03-01       Impact factor: 8.262

2.  Rapid determination of norepinephrine, dopamine, serotonin, their precursor amino acids, and related metabolites in discrete brain areas of mice within ten minutes by HPLC with electrochemical detection.

Authors:  S Murai; H Saito; Y Masuda; T Itoh
Journal:  J Neurochem       Date:  1988-02       Impact factor: 5.372

3.  Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.

Authors:  A J Azzaro; G R Wenger; C R Craig; R E Stitzel
Journal:  J Pharmacol Exp Ther       Date:  1972-03       Impact factor: 4.030

4.  Central monoamines and convulsine thresholds in mice and rats.

Authors:  M Kilian; H H Frey
Journal:  Neuropharmacology       Date:  1973-07       Impact factor: 5.250

5.  Alterations of the cortical noradrenergic system in chronic cobalt epileptogenic foci in the rat: a histofluorescent and biochemical study.

Authors:  S Trottier; B Berger; P Chauvel; J Dedek; M Gay
Journal:  Neuroscience       Date:  1981       Impact factor: 3.590

6.  Carbamazepine pharmacokinetics in young, adult and pregnant rats. Relation to pharmacological effects.

Authors:  B M Assael; L Bossi; S Garattini; M Gerna; R Gomeni; P L Morselli
Journal:  Arch Int Pharmacodyn Ther       Date:  1976-03

7.  Cerebrospinal fluid and serum levels of dopa, catechols, and monoamine metabolites in patients with epilepsy.

Authors:  O Devinsky; S Emoto; D S Goldstein; R Stull; R J Porter; W H Theodore; N S Nadi
Journal:  Epilepsia       Date:  1992 Mar-Apr       Impact factor: 5.864

8.  The concentration of homovanillic and 5-hydroxyindoleacetic acids in ventricular and lumbar CSF. Studies in patients with extrapyramidal disorders, epilepsy, and other diseases.

Authors:  R Papeschi; P Molina-Negro; T L Sourkes; G Erba
Journal:  Neurology       Date:  1972-11       Impact factor: 9.910

9.  Specific and potent interactions of carbamazepine with brain adenosine receptors.

Authors:  P J Marangos; R M Post; J Patel; K Zander; A Parma; S Weiss
Journal:  Eur J Pharmacol       Date:  1983-09-30       Impact factor: 4.432

10.  Carbamazepine decreases catecholamine turnover in the rat brain.

Authors:  P C Waldmeier; P A Baumann; B Fehr; P De Herdt; L Maitre
Journal:  J Pharmacol Exp Ther       Date:  1984-10       Impact factor: 4.030

View more
  8 in total

Review 1.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

2.  Time course of changes in the concentrations of monoamines in the brain structures of pentylenetetrazole-kindled rats.

Authors:  Janusz Szyndler; Piotr Maciejak; Danuta Turzyńska; Alicja Sobolewska; Andrzej Bidziński; Adam Płaźnik
Journal:  J Neural Transm (Vienna)       Date:  2010-05-07       Impact factor: 3.575

Review 3.  Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

Authors:  António F Ambrósio; Patrício Soares-Da-Silva; Caetana M Carvalho; Arsélio P Carvalho
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

Review 4.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

5.  Effect of chronic administration of phenytoin on regional monoamine levels in rat brain.

Authors:  M H Meshkibaf; M N Subhash; K M Lakshmana; B S Rao
Journal:  Neurochem Res       Date:  1995-07       Impact factor: 3.996

6.  Chronic carbamazepine administration attenuates dopamine D2-like receptor-initiated signaling via arachidonic acid in rat brain.

Authors:  Mireille Basselin; Lisa Chang; Mei Chen; Jane M Bell; Stanley I Rapoport
Journal:  Neurochem Res       Date:  2008-02-27       Impact factor: 3.996

7.  Modafinil and its metabolites enhance the anticonvulsant action of classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.

Authors:  Dorota Zolkowska; Marta Andres-Mach; Thomas E Prisinzano; Michael H Baumann; Jarogniew J Luszczki
Journal:  Psychopharmacology (Berl)       Date:  2015-02-21       Impact factor: 4.530

8.  Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats.

Authors:  Opeyemi Samson Osuntokun; Ademola Adeniyi Babatunde; Gbola Olayiwola; Tope Gafar Atere; Olayemi Olutobi Oladokun; Kabiru Isola Adedokun
Journal:  Toxicol Rep       Date:  2021-03-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.